DermaSensor, Inc.

Happy Thanksgiving from the DermaSensor team! We’re grateful for the healthcare professionals and partners who make our work possible. Thank you for your commitment to patient care. Wishing you a safe and restful holiday.

Reposting to give a huge shout-out to Cody Simmons, CEO of DermaSensor, for being recognized as a true innovator driving real change in healthcare! This list highlights companies that aren’t just building cutting-edge tech; they’re solving everyday problems for physicians and patients. Alongside game-changers like Dexcom, Eko Health, Clarius Mobile Health, Exo, and others, DermaSensor is tackling one of healthcare’s key challenges: early detection of skin cancer. Cody and our team have created a point-of-care, non-invasive, and easy-to-use device for routine exams, helping clinicians detect skin lesions of concern so patients can get the care they need. So exciting to see Cody and DermaSensor featured among these trailblazers transforming healthcare in real, tangible ways! https://lnkd.in/e4bpG6xD

The landscape of AI in healthcare is evolving rapidly; however, many tools are still reaching patients without clinical trials or FDA oversight. A recent article from the Duke University School of Medicine, titled “Current Landscape of AI Regulation in Dermatology,” published in JAAD last week, underscores the necessity of strong regulatory standards. The article highlights the DermaSensor device as a robustly validated AI technology that received FDA De Novo authorization, supported by a clinical trial involving over 1,000 patients, which demonstrated 96% sensitivity. Importantly, DermaSensor’s algorithm is a locked model, meaning that the version cleared by the FDA is precisely what primary care physicians utilize in their practice. We agree with the article's viewpoint: both initial authorizations and any future updates to the algorithm must undergo appropriate FDA review to ensure patient safety and promote responsible AI innovation in healthcare. Read the full article here: https://lnkd.in/eb9_EPc8

A great moment for DermaSensor at the MedTech Strategist Innovation Summit, where our CEO, Cody Simmons, presented how our AI-powered spectroscopy device is transforming skin cancer assessment in primary care. We're honored to be part of this distinguished event and proud to stand alongside other innovators in the MedTech ecosystem. See what's possible in point-of-care skin cancer evaluation at https://lnkd.in/eQrESi3t #MedTechStrategist #InnovationSummit #SkinCancer #PrimaryCare #HealthcareInnovation #DigitalHealth #MedTech #AIinHealthcare

💫 Keeping the momentum going with another recognition! DermaSensor received BioFlorida’s 2025 Sales & Distribution of the Year award at the 28th Annual Innovation Conference. The BioFlorida, Inc. Awards Celebration brought together leaders across life sciences, and we’re honored to be recognized among them. Like, share, and follow us as we continue empowering physicians with innovative tools to assess skin cancer risk non-invasively. #BioFlorida #LifeSciences #MedTech #HealthTech #Innovation #DermaSensor

We often hear about the ABCDEs and the "Ugly Duckling" sign when it comes to spotting melanoma — still, melanoma can be deceptive showing up in places or forms you might not expect. This insightful article by The Skin Cancer Foundation dives into the less obvious signs and reinforces why early detection is so critical. A must-read for healthcare professionals, patients, and anyone who cares about protecting their skin. At DermaSensor, we’re proud to support efforts that raise awareness and advance early detection in the fight against skin cancer. 👉 Read the full article: https://lnkd.in/eSKNZtM8 #MelanomaAwareness #SkinHealth #EarlyDetectionSavesLives #DermaSensor

We’re excited to see our CEO, Cody Simmons, join the panel at @LSI USA '26: Beyond Protocols — The Role of AI in Uncharted Treatment and Improving Patient Outcomes. AI is accelerating a new era in diagnostics and clinical decision-making, and we’re proud to contribute to this dialogue alongside leaders shaping the future of care. Looking forward to a great discussion in March 2026. #LSIUSA26 #MedTech #HealthTech #DigitalHealth #AIinHealthcare #MedicalInnovation #DermaSensor

Two newly published studies in JAAD International and JCAD validate the consistent performance of DermaSensor’s FDA cleared, AI-powered device and its ability to improve physicians’ melanoma detection. The studies found: - Melanoma detection increased from 70.2% to 79.1%, decreasing missed melanoma from 29.8% to 20.9%. - 91.5% of the study physicians agreed the device added value to their clinical care. - 75% agreed it would help detect more skin cancers. - 71% reported increased confidence in evaluating skin lesions. Now in use by hundreds of physicians, DermaSensor continues to empower clinicians with rapid, objective lesion assessments — helping bridge gaps in dermatology access and improve patient outcomes. 📄 Read the full press release: https://lnkd.in/eywHqAwB #SkinCancerDetection #PrimaryCare #MedicalDevices #AIinHealthcare #DermaSensor

Technology is transforming how primary care physicians evaluate skin cancer risk. 💡 Dr. Bret Kueber shares how DermaSensor allows him to quickly assess suspicious lesions during routine exams — with no disruption to workflow and immediate results that patients appreciate. Simple. Non-invasive. Backed by AI. Learn how technology like DermaSensor can enhance patient care and confidence in every visit. 👇 Watch Dr. Kueber’s experience and hear why he recommends DermaSensor. #Skincancer #HealthTech #DigitalHealth #MedTech #AIinHealthcare #HealthcareInnovation

Every year, millions of Americans are diagnosed with skin cancer - but most cases can be prevented or treated when caught early. DermaSensor helps physicians non-invasively assess suspicious skin lesions during routine visits, so patients get the reassurance or next steps they need right away. 💙 Find a DermaSensor provider near you: https://lnkd.in/eEdJH9Zm #SkinCancerAwareness #EarlyDetection #SkinHealth #CheckYourSkin #PreventSkinCancer #NonInvasive #PrimaryCare #DermaSensor #SkinCheck #AIinHealthcare #InnovationInMedicine